Prevalence of biopsy-proven nonalcoholic fatty liver among patients with gallstone disease

BACKGROUND/AIM: Gallstone disease (GD) and nonalcoholic fatty liver disease (NAFLD) are associated with metabolic syndrome. Despite the benign nature of NAFLD, 10% of patients may develop advanced fibrosis and cirrhosis. We aimed to identify the prevalence and factors associated with NAFLD among GD...

Descripción completa

Detalles Bibliográficos
Autores principales: Alsaif, Faisal A., Alqahtani, Sara H., Alsadoon, Amani M., Alswat, Khalid A., Abdo, Ayman A., Hassanain, Mazen M., Alsharabi, Abdulsalam B., Aljuhani, Ghadeer R., Alkhalidi, Hisham M., Elsharkawy, Mohammad S., Alotaibi, Maram A., Sanai, Faisal M., Al-hamoudi, Waleed K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580734/
https://www.ncbi.nlm.nih.gov/pubmed/32341228
http://dx.doi.org/10.4103/sjg.SJG_29_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7580734/
https://www.ncbi.nlm.nih.gov/pubmed/32341228
http://dx.doi.org/10.4103/sjg.SJG_29_20

Ejemplares similares